Dermatology Nursing Guide GCC

DHA • DOH • SCFHS • QCHP • MOH — Exam-Ready Clinical Reference • April 2026

Primary Lesion Morphology

LesionDefinitionExamples
MaculeFlat, non-palpable colour change <1 cmFreckle, early vitiligo, petechiae
PapuleRaised, solid lesion <1 cmAcne, molluscum, lichen planus
PlaqueRaised, flat-topped lesion >1 cmPsoriasis, mycosis fungoides
VesicleFluid-filled blister <1 cmHSV, varicella, dyshidrosis
BullaFluid-filled blister >1 cmBullous pemphigoid, TEN, burns
PustulePus-filled lesionAcne, folliculitis, impetigo
NoduleDeep, solid, raised >1 cmLipoma, cyst, melanoma
WhealTransient, oedematous papule/plaque (urticaria)Urticaria, dermographism

Secondary Lesions

Surface Changes

  • Scale: dried flakes of stratum corneum (psoriasis, tinea)
  • Crust: dried serum/pus/blood (impetigo — golden crust)
  • Lichenification: thickened skin with accentuated skin markings (chronic eczema)
  • Excoriation: scratch marks — linear erosions

Depth Changes

  • Erosion: partial-thickness skin loss (stays moist, heals without scar)
  • Ulcer: full-thickness skin loss into dermis/subcutis
  • Fissure: linear crack through epidermis (hand eczema, athlete's foot)
  • Scar: fibrous replacement of dermis — hypertrophic vs. keloid

SCAM Assessment Framework

S
Size
Measure in mm — longest diameter, depth
C
Colour
Uniform vs variegated; erythema, hypo/hyper-pigmentation
A
Appearance
Surface texture, border regularity, satellite lesions
M
Morphology
Primary + secondary lesion types, configuration

Distribution Patterns

  • Photodistributed — sun-exposed: face, V-neck, dorsal hands (lupus, polymorphic light eruption)
  • Flexural — antecubital, popliteal fossa (atopic eczema)
  • Extensor — elbows, knees (psoriasis)
  • Dermatomal — unilateral, follows dermatome (herpes zoster)
  • Intertriginous — skin folds: axilla, groin, submammary (tinea, candida)

Fitzpatrick Skin Type Scale — GCC Relevance

Type I
Always burns, never tans
Rare in GCC
Type II
Usually burns, sometimes tans
Uncommon
Type III
Sometimes burns, always tans
Common GCC
Type IV
Rarely burns, always tans
Predominant
Type V
Very rarely burns, deeply tans
Common GCC
Type VI
Never burns, deeply pigmented
Common GCC
GCC Clinical Pearl: Types III-VI predominate. Erythema (redness) is LESS visible in darker skin types — rashes may appear violaceous or hyperpigmented rather than red. Burns and serious reactions can be missed. Post-inflammatory hyperpigmentation is more pronounced and distressing. Assess for warmth, oedema, and texture changes rather than relying on colour alone.

Dermatoscopy (Dermoscopy) Basics

Purpose

  • 10x magnification of skin structures
  • Reduces unnecessary biopsies by ~50%
  • Differentiates benign vs malignant pigmented lesions
  • Used in combination with ABCDE criteria

Key Patterns

  • Pigment network: regular = benign; irregular/atypical = concern
  • Regression structures: white scar-like areas — melanoma risk
  • Vascular patterns: dotted vessels (melanoma), arborising (BCC)
Two-step algorithm:
Step 1: Is it melanocytic?
Step 2: If melanocytic — is it benign or malignant?

Nursing role: Document findings, photograph for monitoring, refer to dermatologist if any concern

Skin Lesion Descriptive Assessment Tool

Clinical Description (for documentation)

Differential Diagnoses

    Recommended Assessment Actions

      Eczema / Atopic Dermatitis

      SCORAD Scoring

      ComponentMax Score
      Extent (rule of nines %BSA)20
      Intensity (6 signs × 0–3)18
      Subjective (itch + sleep loss)20
      Total max: 103 — <25 mild | 25–50 moderate | >50 severe

      GCC Exacerbation Triggers

      • Heat and excessive sweating (summer temperatures >45°C)
      • Sand and dust exposure (desert environment)
      • Air conditioning — low humidity, dry air
      • Chlorinated water (swimming pools)
      • Synthetic fabrics / abaya/thobe materials

      Treatment Ladder

      1. Emollients: first-line always — apply within 3 min of bathing
      2. Topical corticosteroids (TCS): see potency ladder below
      3. Topical calcineurin inhibitors: tacrolimus 0.1%/0.03%, pimecrolimus 1% — steroid-sparing, safe on face/skin folds
      4. Wet wrap therapy: diluted TCS under wet then dry bandage — severe acute flares
      5. Dupilumab (Dupixent): IL-4/IL-13 inhibitor — moderate-severe refractory, ≥12yrs. Injection site reactions, conjunctivitis risk
      6. Systemic immunosuppressants: ciclosporin, methotrexate, azathioprine
      Topical Corticosteroid Potency Ladder & Finger-Tip Unit Guide
      PotencyExamplesUse Area
      Mild (Class 1)Hydrocortisone 0.5–2.5%Face, groin, axilla, infants — daily use safe
      Moderate (Class 2)Clobetasone butyrate 0.05%, Betamethasone valerate 0.025%Body, limbs — short courses
      Potent (Class 3)Betamethasone valerate 0.1%, Mometasone 0.1%Thick skin areas, scalp — avoid face
      Very Potent (Class 4)Clobetasol propionate 0.05%Palms, soles, lichenified lesions — max 2/52

      Finger-Tip Unit (FTU)

      • 1 FTU = amount squeezed from index finger tip to first crease = ~0.5g
      • Face & neck: 2.5 FTU | Chest or back: 7 FTU each
      • One arm: 3 FTU | One hand (both sides): 1 FTU
      • One leg: 6 FTU | One foot: 2 FTU
      • Apply thin layer — skin should NOT look shiny/wet after application
      Side effects: skin atrophy, striae, telangiectasia, adrenal suppression (extensive use), purpura. Children and face/folds most vulnerable.

      Psoriasis

      PASI Score

      • Body divided into: head, upper limbs, trunk, lower limbs
      • Each area: erythema + induration + scaling (0–4 each)
      • Weighted by BSA involvement
      • Max 72 — PASI <10 mild | 10–20 moderate | >20 severe
      • PASI 75 = 75% improvement = treatment success target

      Special Sites

      • Nail psoriasis: pitting, onycholysis, oil-drop sign, subungual hyperkeratosis — affects up to 50%
      • Scalp psoriasis: thick silvery plaques — use coal tar shampoo, clobetasol solution
      • Psoriatic arthritis: seronegative — affects up to 30%

      Treatment Pathway

      1. Topical: vitamin D analogues (calcipotriol), TCS, combination (Dovobet)
      2. Phototherapy: PUVA (psoralen + UVA) or NB-UVB — max 200 sessions lifetime
      3. Systemic conventional: methotrexate, ciclosporin, acitretin
      4. Biologics:
      ClassExamples
      TNF-α inhibitorsAdalimumab, etanercept, infliximab
      IL-17 inhibitorsSecukinumab, ixekizumab — rapid clearance
      IL-23 inhibitorsGuselkumab, risankizumab — durable remission
      IL-12/23Ustekinumab — 12-weekly dosing

      Contact Dermatitis

      Types

      • Irritant (ICD) ~80%: direct toxic damage — no sensitisation needed. Cumulative hand irritation from detergents, frequent hand washing (HCWs in GCC)
      • Allergic (ACD) ~20%: Type IV delayed hypersensitivity — requires prior sensitisation. Patch testing essential for diagnosis

      Patch Testing

      • Finn chambers applied to upper back
      • Read at 48h and 96h
      • Results: negative / irritant / 1+ to 3+ allergic reactions
      • Standard European baseline series of 30 allergens

      GCC Occupational Context

      Construction workers (largest GCC workforce): cement/chromate — chromate allergy, epoxy resins, cutting oils, rubber accelerators in gloves. Key allergens: potassium dichromate, thiurams, carba mix, nickel, formaldehyde resins.

      Common GCC Allergens

      • Black henna (PPD — paraphenylenediamine)
      • Bakhoor/oud perfume ingredients
      • Gold/nickel (jewellery)
      • Nail cosmetics (acrylates)
      • Latex gloves (healthcare workers)

      Bacterial Skin Infections

      Impetigo

      • Non-bullous (70%): Staph. aureus / Strep. pyogenes — golden crusted erosions around nose/mouth
      • Bullous: Staph. aureus toxin — flaccid bullae on trunk
      • Rx: mupirocin 2% topical (limited) | oral flucloxacillin or cefalexin 500mg QDS 7 days
      • Highly contagious — school/work exclusion until crusts resolved

      Erysipelas

      • Superficial dermis — Group A Strep, sharply demarcated raised border
      • Usually face or leg — bright red, warm, oedematous, systemic upset
      • Rx: benzylpenicillin IV or amoxicillin PO

      Cellulitis

      • Deeper dermis/subcutaneous — less sharp border than erysipelas
      • LRINEC score (Laboratory Risk Indicator for Necrotising Fasciitis): CRP, WCC, haemoglobin, sodium, creatinine, glucose — score <6 low risk | 6–7 intermediate | >8 high risk NF
      • Mark border with surgical pen — reassess 1-2 hourly to monitor spread
      • IV flucloxacillin if systemically unwell; co-amoxiclav for polymicrobial risk (diabetics, bites)

      MRSA Skin Infections

      • Suspect if failure of standard antibiotics
      • Community MRSA: painful boils/abscesses — incision & drainage + doxycycline/trimethoprim
      • Hospital MRSA: vancomycin IV or linezolid; contact isolation
      Necrotising Fasciitis — LRINEC Scoring & Surgical Emergency Pathway
      ParameterValuePoints
      CRP (mg/L)≥1504
      WCC (×10⁹/L)15–25 / >251 / 2
      Haemoglobin (g/dL)11–13.5 / <111 / 2
      Sodium (mmol/L)<1352
      Creatinine (μmol/L)>1412
      Glucose (mmol/L)>101
      LRINEC ≥6 = HIGH SUSPICION — SURGICAL EMERGENCY
      Finger Test: Under LA, 2cm incision over suspicious area. Absence of bleeding, grey necrotic tissue, no resistance to finger dissection = POSITIVE → immediate theatre for surgical debridement.

      Emergency pathway: 1) Call surgeon immediately 2) Broad-spectrum IV antibiotics: piperacillin-tazobactam + clindamycin + vancomycin 3) IV fluids/resus 4) ICU 5) Theatre within 6 hours — mortality increases 9% per hour of delay 6) Hyperbaric oxygen adjunct where available

      Fungal Infections

      ConditionOrganismPresentationTreatment
      Tinea pedis (athlete's foot)Trichophyton rubrumInterdigital maceration, scaling, pruritusClotrimazole 1% cream 4/52 or terbinafine 1% cream 1/52
      Tinea corporis (ringworm)T. rubrum, T. tonsuransAnnular scaly plaque with central clearingTopical terbinafine/clotrimazole; oral for extensive
      Tinea capitisT. tonsurans, MicrosporumScaly scalp patches, broken hairs, lymphadenopathyOral griseofulvin or terbinafine 4–8 weeks
      OnychomycosisDermatophytes/CandidaThickened, discoloured, brittle nailsOral terbinafine: 250mg daily — 6wks fingernails, 12wks toenails. Monitor LFTs. Amorolfine lacquer adjunct
      Pityriasis versicolorMalassezia furfurHypo/hyper-pigmented patches on trunk — GCC: very common in heat/sweatKetoconazole 2% shampoo applied 5 min daily ×5 days; selenium sulfide. Recurrence common

      Viral Skin Infections

      Herpes Zoster (Shingles)

      • Reactivation of VZV from dorsal root ganglia
      • Prodrome: burning/tingling/pain in dermatomal distribution 1–4 days before rash
      • Vesicular rash in single dermatome — never crosses midline
      • Treatment: aciclovir 800mg 5× daily × 7 days — MUST START WITHIN 72h of rash onset for maximum benefit
      • Analgesia: paracetamol/ibuprofen, consider amitriptyline/gabapentin early to prevent PHN
      • Ophthalmic zoster (V1) → same-day ophthalmology review
      • Post-herpetic neuralgia (PHN): pain persisting >3 months — older patients, severe acute pain = risk factors

      Herpes Simplex Virus (HSV)

      • HSV-1: oro-labial / HSV-2: genital (overlap increasingly common)
      • Primary episode: painful grouped vesicles/ulcers, systemic upset
      • Recurrent: prodromal tingling, milder episode
      • Rx: aciclovir 200mg 5× daily × 5 days (primary); topical aciclovir for labial HSV
      • Suppressive therapy for ≥6 recurrences/year: aciclovir 400mg BD

      Molluscum Contagiosum

      • Poxvirus — umbilicated pearly papules
      • Mostly self-limiting in immunocompetent — 6–18 months
      • Extensive disease — consider HIV screen in adults

      Infestations

      Scabies — GCC Healthcare Settings Treatment Protocol
      GCC Context: Scabies outbreaks common in shared accommodation — migrant workers in construction/domestic sectors. Highly contagious — entire household/close contacts MUST be treated simultaneously even if asymptomatic.

      First-Line Treatment

      • Permethrin 5% cream: Apply from neck to toes (including under nails, between fingers, genitalia). Leave 8–12 hours. Wash off. Repeat after 7 days.
      • For head/neck in elderly, immunocompromised, infants: apply to face also
      • Nails: trim short, apply cream under nails with soft brush

      Second-Line / Crusted Scabies

      • Oral ivermectin 200 mcg/kg — 2 doses 1–2 weeks apart. Not in pregnancy/infants <15kg.
      • Crusted (Norwegian) scabies: combination permethrin + ivermectin + keratolytics. Contact isolation essential.

      Environmental Decontamination

      • Wash all clothing, bed linen, towels at 60°C or higher
      • Items that cannot be washed: seal in plastic bags for 72 hours (mites die without human host)
      • Treat all household/dormitory contacts on SAME DAY
      • Pruritus may persist 2–6 weeks after successful treatment — reassure, antihistamines for itch

      Healthcare Setting Protocol

      • Contact precautions: gloves + gown — until 24h after first treatment
      • Notify occupational health — screen and treat exposed HCWs
      • Document outbreak — report to infection control team per DHA/DOH policy

      Head Lice (Pediculosis Capitis)

      • Diagnosis: visualise live louse or nit within 1cm of scalp
      • Rx: dimeticone 4% lotion × 2 applications 7 days apart — no resistance issue (physical action)
      • Alternative: malathion 0.5% or wet combing (detection combing) if chemical aversion
      • Treat all household members simultaneously; fine-tooth combing — wet hair + conditioner

      Stevens-Johnson Syndrome (SJS) & Toxic Epidermal Necrolysis (TEN)

      DRUG REACTION EMERGENCY — Stop causative drug IMMEDIATELY
      Common culprits: allopurinol (most common GCC — gout treatment), carbamazepine, lamotrigine, sulfonamides (co-trimoxazole), NSAIDs, nevirapine

      Classification by % BSA Detachment

      • SJS: <10% BSA — still serious
      • Overlap: 10–30% BSA
      • TEN: >30% BSA — mortality up to 50%

      SCORTEN Mortality Score

      Calculated at day 1. 1 point each: age >40, malignancy, HR >120, initial BSA >10%, serum urea >10, glucose >14, bicarbonate <20

      ScorePredicted Mortality
      0–13.2%
      212.1%
      335.3%
      458.3%
      ≥5>90%

      Management

      1. Stop ALL suspected drugs immediately
      2. ICU or burns unit admission
      3. Ophthalmology review — ocular involvement leads to blindness
      4. Strict fluid balance — treat like burns (IV fluid resuscitation)
      5. Nutritional support (NG feeding) — protein loss from skin
      6. Temperature regulation — warm environment (skin barrier lost)
      7. Wound care — non-adhesive dressings; avoid skin stripping
      8. Oral care — mucosal involvement — chlorhexidine mouthwash, lip care
      9. Genital care — urethral/vaginal mucosal involvement
      Pharmacological controversy: Corticosteroids — evidence mixed; most experts avoid in TEN. IV immunoglobulin (IVIG) and cyclosporin used in specialist centres — limited evidence but widely used in GCC.

      Erythroderma

      Definition: Erythema covering >90% BSA. Dermatological emergency — significant morbidity from thermoregulatory failure, protein loss, high-output cardiac failure.

      Causes (mnemonic: PSALM-D)

      • Psoriasis (most common) — 25%
      • Skin conditions — eczema, seborrhoeic
      • Allergic/drug reactions
      • Lymphoma / cutaneous T-cell (Sézary syndrome)
      • Miscellaneous — rare dermatoses
      • De novo (no identifiable cause) — ~25%

      Nursing Management

      • 4-hourly vital signs — HR, BP, temperature, oxygen saturation
      • Temperature regulation: warm environment (skin barrier impaired — hypothermia risk)
      • Daily weights — fluid balance assessment
      • Regular emollient application — white soft paraffin or aqueous cream bath
      • Monitor albumin, electrolytes — protein exudate from skin surface
      • High-protein high-calorie diet or dietitian review
      • Daily skin assessment — blistering, secondary infection signs

      Autoimmune Blistering Disorders

      Pemphigus Vulgaris

      • IgG autoantibody against desmoglein 3 (and 1) — intra-epidermal split
      • Flaccid blisters — rupture easily leaving painful erosions
      • Oral mucosa ALWAYS involved (may precede skin by months)
      • Nikolsky's sign POSITIVE: lateral pressure on normal skin causes skin to slide/blister
      • Rx: high-dose prednisolone + azathioprine/mycophenolate; rituximab for refractory cases
      • Monitor: blood glucose (steroid-induced DM), BP, osteoporosis prophylaxis

      Bullous Pemphigoid

      • IgG autoantibody against BP180/BP230 — sub-epidermal split
      • Tense blisters on erythematous/urticarial base — elderly patients (>70 years)
      • Oral involvement less common than PV
      • Nikolsky's sign NEGATIVE (tense bullae, sub-epidermal)
      • Pruritus often severe before blisters appear
      • Rx: potent topical clobetasol, oral prednisolone, doxycycline + nicotinamide; azathioprine steroid-sparing

      Melanoma — ABCDE Criteria & Management

      ABCDE Criteria

      LetterFeatureConcern
      A — AsymmetryShapeIrregular, asymmetrical
      B — BorderEdgeIrregular, notched, blurred
      C — ColourPigmentationVariegated — brown, black, red, white
      D — DiameterSize>6mm (pencil eraser) — but early can be smaller
      E — EvolutionChangeGrowing, changing, new ulceration/bleeding

      Staging & Prognosis

      • Breslow thickness: depth of invasion in mm — single most important prognostic factor
      • <1mm = excellent prognosis | 1–4mm = intermediate | >4mm = poor
      • Clark level: anatomical depth (I–V)
      • Sentinel lymph node biopsy (SLNB): for Breslow >1mm or <1mm with high-risk features (ulceration, mitoses)
      GCC Note: Melanoma may be amelanotic (non-pigmented) — particularly on palms/soles/nail beds (acral lentiginous type) — more common in darker skin types but STILL occurs. High index of suspicion for non-healing lesions on acral surfaces.

      Pressure Injury Staging — NPIAP Classification

      StageDescriptionKey Features
      Stage INon-blanchable erythema of intact skinSkin intact; redness does NOT blanch with 30s pressure; may be darker discolouration in dark skin types
      Stage IIPartial thickness skin lossOpen shallow wound with red/pink wound bed OR intact/ruptured serum-filled blister. No slough/eschar.
      Stage IIIFull thickness skin lossSubcutaneous fat visible; slough/eschar may be present; no exposed bone/tendon/muscle. Tunnelling possible.
      Stage IVFull thickness tissue lossExposed bone, tendon, or muscle; slough/eschar; often tunnelling and undermining.
      UnstageableDepth unknown — covered by slough/escharCannot stage until base visible. Stable dry eschar on heels = do NOT remove (natural protection)
      Deep TissuePersistent non-blanchable deep red/maroon/purple discolourationIntact or non-intact skin; pressure/shear injury to soft tissue. May rapidly deteriorate to Stage III/IV.

      Braden Scale Risk Assessment

      SubscaleScore Range
      Sensory perception1–4
      Moisture1–4
      Activity1–4
      Mobility1–4
      Nutrition1–4
      Friction & shear1–3
      Total6–23

      Risk Categories

      • 19–23: No risk
      • 15–18: Mild risk
      • 13–14: Moderate risk
      • 10–12: High risk
      • ≤9: Very high risk
      Reassess: on admission, after surgery, change in condition — at least 48-hourly in acute settings. Braden ≤18 triggers pressure injury prevention protocol.

      Offloading & Prevention

      • Reposition: 2-hourly minimum for high-risk patients; 30-degree tilt (not 90-degree lateral) to avoid trochanteric pressure
      • Reactive foam or alternating pressure mattresses for Braden ≤18
      • Heel protectors — elevate heels off mattress completely (float the heels)
      • Skin: keep clean and dry, moisture-barrier cream for incontinence, avoid massage over bony prominences

      Wound Bed Preparation — TIME Framework

      T
      Tissue
      Debride non-viable tissue: autolytic/enzymatic/sharp/surgical
      I
      Infection/Inflammation
      Treat clinical infection; reduce bioburden; antimicrobial dressings
      M
      Moisture
      Moist wound healing; manage exudate — too dry or too wet both impede healing
      E
      Edge/Epithelium
      Assess wound edge advancement; consider skin grafting if edge not advancing in 4 weeks

      Dressing Selection Guide

      Dressing TypeIndicationAvoid
      HydrocolloidStage II, minimal-moderate exudate, autolytic debridementHeavy exudate, infected wounds, Stage III/IV
      FoamModerate-heavy exudate, Stage II/III, cavity (cavity foam)Dry/necrotic wounds
      AlginateHeavy exudate, bleeding wounds (haemostatic), cavity woundsDry wounds, Stage I, wounds with sinuses (packing risk)
      Hydrofibre (Aquacel)Heavy exudate, infected wounds — forms gel, maintains moistureDry wounds
      Silicone (Mepitel)Fragile skin, epidermolysis bullosa, donor sites, burnsHeavy exudate (use silicone foam instead)
      Antimicrobial silverInfected/critically colonised wounds, chronic non-healing woundsClean healing wounds — cytotoxic to fibroblasts if overused
      Honey (Medihoney)Infected, malodorous, sloughy wounds — antimicrobial, debridingAllergy to bee products, heavy exudate alone

      Negative Pressure Wound Therapy (NPWT / VAC)

      Indications

      • Stage III/IV pressure injuries
      • Diabetic foot ulcers — post-surgical or traumatic
      • Dehisced surgical wounds
      • Open abdominal wounds / laparostomy
      • Skin graft fixation and take optimisation

      How it works

      • Continuous or intermittent negative pressure (typically -125 mmHg)
      • Reduces oedema, removes exudate, promotes granulation tissue
      • Draws wound edges together (macro-deformation)

      Contraindications

      • Malignancy in or near wound — promotes tumour growth
      • Unexplored fistula / enteric fistula
      • Necrotic tissue with eschar — must debride first
      • Untreated osteomyelitis
      • Active bleeding / anticoagulated patient — caution

      Nursing Monitoring

      • Check seal integrity — leaks lose therapeutic pressure
      • Monitor canister output — excessive sudden blood = alarm
      • Change foam/gauze every 48–72h (or per manufacturer)
      • Pain assessment — intermittent mode more painful than continuous

      Leg Ulcers — Venous vs Arterial vs Mixed

      FeatureVenousArterialMixed
      LocationMedial gaiter (medial malleolus)Lateral, pressure points, toesVariable
      Wound bedShallow, exudative, granulatingDeep, pale/grey/necrotic, dryMixed features
      EdgesIrregular, slopingPunched-out, well-definedVariable
      PainDull ache, relieved by elevationSevere, worse at night/elevation (rest pain)Mixed
      Surrounding skinLipodermatosclerosis, haemosiderin staining, varicositiesHairless, shiny, cold, pale/duskyMixed
      ABPI0.8–1.3 (normal)<0.5 (severe ischaemia)0.5–0.8
      CompressionHIGH compression (40mmHg) — first-lineCONTRAINDICATED if ABPI <0.5Modified compression only if ABPI >0.6
      ABPI (Ankle-Brachial Pressure Index) MUST be assessed before applying compression therapy. Use handheld Doppler. Normal ABPI 0.9–1.3. <0.9 = peripheral arterial disease. Never apply full compression (25–40 mmHg) to ABPI <0.8 without vascular review.

      Heat-Related Skin Conditions — GCC Outdoor Workers

      Miliaria (Prickly Heat)

      • Crystallina: superficial eccrine duct blockage — clear vesicles, no inflammation. Self-limiting
      • Rubra: deeper — erythematous papulovesicles, pruritic/stinging. Most common
      • Profunda: deepest — skin-coloured papules. Risk of heat exhaustion (sweat impaired)
      • Rx: cool environment, loose cotton clothing, calamine lotion, mild TCS for rubra

      Sunburn

      • UVB-induced erythema, oedema, pain — peaks 12–24h after exposure
      • GCC: even darker skin types (III-VI) WILL burn — less visible erythema but still DNA damage
      • Rx: cool compresses, emollients, ibuprofen, SPF 30-50 prevention
      GCC Outdoor Worker Risk:
      Summer ban on outdoor work 12:30–15:00 (June-Sept) — enforced in UAE, Qatar, Saudi Arabia. Skin conditions UNDERREPORTED in migrant workers due to fear of job loss.

      Photosensitivity in dark skin: Erythema less visible — assess warmth, oedema, patient-reported burning/pain. Risk of missing significant burns. Higher SPF compliance messaging needed.

      Nursing Role — Outdoor Workers

      • Health education: SPF 50+, protective clothing, hydration
      • Sunscreen prescription — available OTC in GCC pharmacies
      • Screen for occupational dermatoses during annual health checks
      • Refer to occupational health for persistent/severe conditions

      GCC-Specific Skin Conditions

      Animal-Contact Conditions

      • Camel Pox: Poxvirus — papules/pustules on hands/arms from contact with infected camels. Zoonotic. Notify public health. Rare human-to-human spread.
      • Orf (Contagious Ecthyma): Parapoxvirus from sheep/goats — common during Eid Al-Adha (mass slaughter). Solitary nodule on hand that progresses through 6 stages over 6 weeks. Self-limiting. Immunocompromised — giant orf.
      • Desert sores (tropical ulcer): Mixed bacterial infection on lower limbs — found in areas with contaminated soil/water

      Climate-Related Conditions

      • Tinea imbricata: Trichophyton concentricum — concentric ring pattern, SE Asian migrants in GCC, oral terbinafine extended course
      • Photodermatoses: Polymorphic light eruption — very common in GCC given sun exposure; pruritic papules/vesicles on exposed skin
      • Chromhidrosis: Coloured sweat — apocrine (face/axillae) — rare; eccrine blue sweat from copper exposure in industrial workers

      Cultural & Religious Skin Considerations in GCC

      Henna Dermatitis

      • Natural henna (Lawsonia inermis) — orange/brown colour, low sensitisation risk
      • Black henna — contains paraphenylenediamine (PPD) to darken/speed up colour. HIGH risk of severe ACD — can cause scarring
      • PPD allergy also cross-reacts with: hair dye, benzocaine, sulfonamides, procaine — important surgical/drug allergy implication
      • Patch test before henna application — educate patients about black henna risk

      Bakhoor/Oud/Perfume Reactions

      • Arabic perfume oils (attar/oud) — applied directly to skin — fragrance mix allergy common
      • Bakhoor (incense burning) — airborne contact dermatitis possible
      • Cinnamal, limonene, linalool — common fragrance allergens

      Vitiligo — GCC Psychosocial Context

      Vitiligo (autoimmune depigmentation) has significant psychosocial impact in GCC due to visibility on darker skin types. Important Islamic context: vitiligo is NOT contagious — educate patients, families, communities. Historical stigma (baras = leprosy confusion) contributes to social isolation. Psychological support, patient education, and community de-stigmatisation are core nursing roles.

      Rx: phototherapy (NB-UVB — gold standard), topical tacrolimus for face/sensitive areas, camouflage cosmetics, JAK inhibitors (ruxolitinib cream) — newer approval.

      Modesty & Gender Considerations

      • Female patients may prefer female nurses for skin examination — accommodate where possible
      • Full skin examination may require sensitive communication and privacy
      • Body image concerns from religious/cultural attire interactions with skin conditions (hijab dermatitis, friction under abaya)

      GCC Regulatory & Nursing Competencies

      Licensing Body Frameworks

      CountryBodyDermatology Relevance
      DubaiDHAWound care competency assessment; dermatology nursing clinical attachment requirements
      Abu DhabiDOHScope of practice for nurses in wound care, IV antibiotics
      Saudi ArabiaSCFHSWound care certification program — mandatory for wound care nurses
      QatarQCHPNursing licence with specialisation pathway; CPD requirements
      All GCCMOH variationsMCQ licensing exams — dermatology questions included

      SCFHS Wound Care Certification

      • Structured wound care program — recognised across Saudi Arabia
      • Covers: pressure injury prevention, chronic wound management, dressing selection, diabetic foot care
      • CPD hours required for renewal
      • Increasingly required for wound care specialist nurse roles in MOH hospitals
      Nursing Scope in GCC Dermatology:
      Wound care, dressing changes, phototherapy operation (NB-UVB units), topical treatment education, patch test preparation (under dermatologist supervision), biopsy preparation, patient education — cultural skin health promotion.

      GCC Exam Prep — DHA / MOH / SCFHS / QCHP Style MCQs

      Q1. A 35-year-old male construction worker in Dubai presents with intensely pruritic, erythematous papulovesicles in the webspaces of his fingers and on his wrists. His dormitory roommates have similar symptoms. What is the most appropriate FIRST treatment step?
      1. Prescribe oral flucloxacillin for all symptomatic contacts
      2. Apply permethrin 5% cream from neck to toe, treat ALL household contacts on the SAME day
      3. Apply hydrocortisone 1% cream twice daily for 2 weeks
      4. Refer to dermatology and await patch testing results
      Answer: B — This presentation is classic scabies (pruritic burrows in webspaces, household spread). Permethrin 5% is first-line; simultaneous treatment of ALL contacts prevents reinfestation. Topical steroids alone will worsen scabies. Flucloxacillin is for bacterial infections.
      Q2. A 52-year-old patient on carbamazepine for epilepsy develops painful mucosal erosions, target lesions, and skin detachment affecting 8% of body surface area. What is the PRIORITY nursing action?
      1. Apply potent topical corticosteroids to all affected areas immediately
      2. Stop the carbamazepine and arrange urgent ophthalmology review
      3. Commence oral antihistamines and observe for 24 hours
      4. Apply silver sulfadiazine cream and discharge with outpatient follow-up
      Answer: B — 8% BSA detachment = Stevens-Johnson Syndrome. STOP causative drug IMMEDIATELY (carbamazepine). Ophthalmology review is urgent (ocular involvement leads to blindness). Topical steroids are controversial and not the priority. This patient needs ICU/burns unit admission, not discharge.
      Q3. When performing ABPI (Ankle-Brachial Pressure Index) before applying compression bandaging to a patient with a venous leg ulcer, a reading of 0.6 is obtained. What is the CORRECT action?
      1. Apply full 4-layer high compression bandaging (40 mmHg) as planned
      2. Do not apply any compression and refer immediately to vascular surgery
      3. Apply modified/reduced compression (15–20 mmHg) only after vascular review
      4. Obtain a repeat ABPI in 4 hours and proceed if unchanged
      Answer: C — ABPI 0.5–0.8 indicates mixed aetiology (venous + arterial). Full compression is CONTRAINDICATED (ABPI <0.8). Modified reduced compression (15–20 mmHg) may be used after vascular assessment confirms safety. ABPI <0.5 = severe ischaemia — no compression at all.
      Q4. A patient with a chronic Stage III pressure injury has a Braden Scale score of 10. The wound bed is covered with yellow slough. Using the TIME framework, which is the FIRST priority intervention?
      1. Apply a silver antimicrobial dressing to address infection risk
      2. Commence negative pressure wound therapy (VAC) immediately
      3. Debride the necrotic/sloughy tissue to prepare the wound bed (Tissue)
      4. Apply a hydrocolloid dressing to maintain moisture balance
      Answer: C — TIME framework: T (Tissue) is addressed first — non-viable sloughy tissue must be debrided before other interventions can be effective. A Braden score of 10 = high risk; NPWT may be indicated but debridement comes first. Hydrocolloid is inappropriate for Stage III with heavy slough.
      Q5. A Saudi nurse is counselling a patient newly diagnosed with vitiligo. The patient's family is concerned about contagion. Which statement is MOST important to include in patient education?
      1. Vitiligo is caused by a fungal infection and can spread through skin contact
      2. Vitiligo is an autoimmune condition — it is NOT contagious and cannot be passed to others
      3. The condition is linked to poor hygiene and will resolve with regular washing
      4. Patients with vitiligo should be isolated in shared spaces to prevent spread
      Answer: B — Vitiligo is an autoimmune destruction of melanocytes. It is completely non-contagious. This is especially important in GCC cultural context where historical stigma (confusion with leprosy/baras) causes social isolation. Education should address the family and community. Isolation is incorrect and harmful.
      GCC Dermatology Nursing Guide • For educational purposes only • Always follow local clinical guidelines • DHA / DOH / SCFHS / QCHP / MOH